advanced search

Welcome: Guest

log in

Carl Zeiss Meditec AG Product Pipeline Analysis

Publication Date August 2008
Publisher Global Markets Direct
Product Type Report
Pages 47
ISBN Number not applicable
Product Code GMD04818
Price

£490.00
approximately: $749 | €546

PDFBuy Now
Order above formats by FAXOrder by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Carl Zeiss Meditec AG's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Financial Performance
  • 3 Business Description
    • 3.1 Business Overview
    • 3.2 Neuro/ENT
      • 3.2.1 Overview
      • 3.2.2 Financials
      • 3.2.3 Capital Expenditure
      • 3.2.4 Market View
      • 3.2.5 Key Strategies
    • 3.3 Ophthalmic Systems
      • 3.3.1 Overview
      • 3.3.2 Financials
      • 3.3.3 Market View
      • 3.3.4 Key Strategies
      • 3.3.5 Capital Expenditure
    • 3.4 Ophthalmic Systems
      • 3.4.1 Overview
      • 3.4.2 Financials
      • 3.4.3 Market View
      • 3.4.4 Key Strategies
    • 3.5 Surgical Ophthalmology
      • 3.5.1 Overview
      • 3.5.2 Financials
      • 3.5.3 Capital Expenditure
      • 3.5.4 Market View
    • 3.6 Major Products and Services
      • 3.6.1 Overview
  • 4 Business Strategy
    • 4.1 Mission Statement
    • 4.2 Strategy
    • 4.3 Corporate Social Responsibility
      • 4.3.1 Overview
  • 5 Value Chain Analysis
    • 5.1 Manufacturing
      • 5.1.1 In House Manufacturing
      • 5.1.2 Outsourcing
    • 5.2 Product Development
      • 5.2.1 Regulatory Approvals
      • 5.2.2 Clinical Trials
      • 5.2.3 Research and Development
    • 5.3 Sales and Marketing
      • 5.3.1 Partnerships and Alliances
      • 5.3.2 Licensing Agreements
  • 6 Competitors
  • 7 Key Employees
  • 8 Key Employee Biographies
  • 9 Company Statement
  • 10 Locations And Subsidiaries
    • 10.1 Head Office
    • 10.2 Other Locations & Subsidiaries
  • 11 Recent Developments
    • 11.1 Strategy And Business Planning
      • 11.1.1 Apr 30, 2008: Carl Zeiss Opens Technology Center In India
      • 11.1.2 Mar 27, 2008: CZM Opens Advanced Imaging Centre At Singapore
    • 11.2 Financial Announcements
      • 11.2.1 Aug 14, 2008: CZM Reports First Nine Months 2008 Results
      • 11.2.2 May 13, 2008: CZM Reports H1 2007/08 Results
      • 11.2.3 Aug 08, 2007: CZM First Nine Months 2007 Results
      • 11.2.4 Mar 01, 2007: CZM Reports Fiscal 2005/06 Results
      • 11.2.5 Feb 14, 2007: CZM Reports Q1 2006/07 Results
    • 11.3 Corporate Communications
      • 11.3.1 Jul 21, 2008: CZM Announces Management Board Changes
      • 11.3.2 Apr 25, 2008: Carl Zeiss Vision Appoints COO
      • 11.3.3 Oct 08, 2007: CZM Appoints New Board Member
      • 11.3.4 Aug 23, 2007: CZM Announces Supervisory Board Changes
      • 11.3.5 Sep 11, 2006: CZM Appoints Executive Board Member
    • 11.4 Legal and Regulatory
      • 11.4.1 Nov 13, 2006: CZM Lawsuit with IntraLase
      • 11.4.2 Oct 13, 2006: CZM Wins Against Complainants In Court
    • 11.5 Product News
      • 11.5.1 Jul 17, 2008: Carl Zeiss Meditec Reaches 1,000 Cirrus HD-OCT Placements
      • 11.5.2 Apr 04, 2008: Carl Zeiss Meditec Delivers Key Technological Advances In Optical Coherence Tomography
      • 11.5.3 Apr 04, 2008: Carl Zeiss To Introduce Stratus OCT At The American Society Of Cataract And Refractive Surgeons
      • 11.5.4 Mar 10, 2008: Carl Zeiss Meditec Inc. Introduces New Humphrey Field Analyzer
      • 11.5.5 Mar 06, 2008: Carl Zeiss Meditec Introduces First Femtosecond Laser In Asia
      • 11.5.6 Nov 13, 2007: Carl Zeiss Meditec Introduces OPMI pico Microscope
  • 12 Carl Zeiss Meditec AG Pipeline Products
    • 12.1 Carl Zeiss Meditec AG Product Pipeline Analysis
      • 12.1.1 Carl Zeiss Meditec AG Pipeline Products By Equipment Type
      • 12.1.2 Carl Zeiss Meditec AG Pipeline Products By Development Stage
      • 12.1.3 Carl Zeiss Meditec AG Pipeline Products By Therapy Area
      • 12.1.4 Carl Zeiss Meditec AG Pipeline Products By Clinical Trials
    • 12.2 IOL Master
      • 12.2.1 Product Description
      • 12.2.2 Product Status
    • 12.3 VISULAS 690 PLUS
      • 12.3.1 Product Description
      • 12.3.2 Product Status
    • 12.4 Multifocal IOL
      • 12.4.1 Product Description
      • 12.4.2 Product Status
    • 12.5 New laser system
      • 12.5.1 Product Description
      • 12.5.2 Product Status
    • 12.6 VISUCAM platform-New applications
      • 12.6.1 Product Description
      • 12.6.2 Product Status
      • 12.6.3 Clinical Trials
      • 12.6.4 Product Patent Details
  • 13 Appendix
    • 13.1 Methodology
      • 13.1.1 Coverage
      • 13.1.2 Secondary Research
      • 13.1.3 Primary Research
      • 13.1.4 Expert Panel Validation
    • 13.2 Contact Us
    • 13.3 About Global Markets Direct
    • 13.4 Disclaimer
  • 1 List of Tables
    • Table 1: Carl Zeiss Meditec AG,Key Facts, 2007
    • Table 2: Carl Zeiss Meditec AG, Key Employees, 2007
    • Table 3: Carl Zeiss Meditec AG, Other Locations
    • Table 4: Carl Zeiss Meditec AG, Subsidiaries
    • Table 5: Carl Zeiss Meditec AG Pipeline Products by Equipment Type
    • Table 6: Carl Zeiss Meditec AG Pipeline Products By Development Stage
    • Table 7: Carl Zeiss Meditec AG Pipeline Products By Therapy Area
    • Table 8: Carl Zeiss Meditec AG Pipeline Products By Clinical Trials
    • 1.2 List of Figures
    • Figure 1: Carl Zeiss Meditec AG, Value Chain Analysis
    • Figure 2: Carl Zeiss Meditec AG Pipeline Products By Equipment Type
    • Figure 3: Carl Zeiss Meditec AG Pipeline Products By Equipment Type
    • Figure 4: Carl Zeiss Meditec AG Pipeline Products By Development Stage
    • Figure 5: Global Markets Direct Methodology